Efficacy of single versus four repeated doses of praziquantel against Schistosoma mansoni infection in school-aged children from Côte d'Ivoire based on Kato-Katz and POC-CCA: An open-label, randomised controlled trial (RePST)-Reference-Cited by-同舟云学术

Efficacy of single versus four repeated doses of praziquantel against Schistosoma mansoni infection in school-aged children from Côte d'Ivoire based on Kato-Katz and POC-CCA: An open-label, randomised controlled trial (RePST)

Published:2020-03-20 Issue:3 Volume:14 Page:e0008189
ISSN:1935-2735
Container-title:PLOS Neglected Tropical Diseases
language:en
Short-container-title:PLoS Negl Trop Dis

Author:

Hoekstra Pytsje T.^ORCID,Casacuberta-Partal Miriam,van Lieshout Lisette,Corstjens Paul L. A. M.,Tsonaka Roula,Assaré Rufin K.,Silué Kigbafori D.,Meité Aboulaye,N’Goran Eliézer K.,N’Gbesso Yves K.,Amoah Abena S.,Roestenberg Meta,Knopp Stefanie,Utzinger Jürg,Coulibaly Jean T.,van Dam Govert J.

Funder

Prof. dr. P.C. Flu Foundation

The Task Force for Global Health

Publisher

Public Library of Science (PLoS)

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Reference63 articles.

1. WHO. Schistosomiasis 2019 [Available from: https://www.who.int/en/news-room/fact-sheets/detail/schistosomiasis].

2. The global burden of disease study 2010: interpretation and implications for the neglected tropical diseases;PJ Hotez;PLoS Negl Trop Dis,2014

3. Human schistosomiasis;DG Colley;Lancet,2014

4. Schistosomiasis;DP McManus;Nat Rev Dis Primers,2018

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SCHISTOACT: a protocol for an open-label, five-arm, non-inferiority, individually randomized controlled trial of the efficacy and safety of praziquantel plus artemisinin-based combinations in the treatment of Schistosoma mansoni infection;Trials;2023-11-27

2. Chronic schistosomiasis imported in France: A retrospective multicentre analysis of 532 patients, calling for international recommendations;Travel Medicine and Infectious Disease;2023-11

3. SCHISTOACT: A protocol for an open-label, five-arm, non-inferiority, individually randomized controlled trial of the efficacy and safety of Praziquantel plus Artemisinin-based combinations in the treatment of Schistosoma mansoni infection;2023-08-24

4. Reproducibility matters: intra- and inter-sample variation of the point-of-care circulating cathodic antigen test in two Schistosoma mansoni endemic areas in Uganda;Philosophical Transactions of the Royal Society B: Biological Sciences;2023-08-21